Android app on Google Play

Impax Laboratories Inc. (IPXL) Tops Q4 EPS by 4c

February 25, 2013 4:02 PM EST Send to a Friend
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q4 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $141.1 million versus the consensus estimate of $127.03 million.

For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment